Trademark: 79162625
Status Date
Friday, April 22, 2022
Registration Number
4824525
Registration Date
Tuesday, October 6, 2015
Filing Date
Friday, February 27, 2015
Published for Opposition
Tuesday, July 21, 2015
Cancellation Date
Friday, April 22, 2022
5 Pharmaceutical products for the treatment of retinal dystrophy, retinitis pigmentosa, and disorders of the retina
Mar 14, 2023
Total Invalidation Processed By The Ib
Feb 16, 2023
Total Invalidation Of Reg Ext Protection Sent To Ib
Feb 16, 2023
Invalidation Processed
Dec 22, 2022
Total Invalidation Of Reg Ext Protection Created
Apr 22, 2022
Cancelled Section 71
Oct 6, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 15, 2017
Change Of Name/Address Rec'd From Ib
Apr 6, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 6, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 22, 2016
Notification Processed By Ib
Dec 30, 2015
Final Disposition Notice Sent To Ib
Dec 30, 2015
Final Disposition Processed
Nov 5, 2015
Grant Of Protection Created, To Be Sent To Ib
Oct 6, 2015
Registered-Principal Register
Jul 21, 2015
Published For Opposition
Jul 1, 2015
Notice Of Publication
Jun 9, 2015
Approved For Pub - Principal Register
Jun 4, 2015
Assigned To Examiner
Apr 7, 2015
Application Filing Receipt Mailed
Apr 3, 2015
New Application Office Supplied Data Entered
Apr 2, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
